Coxsackievirus B5 induced apoptosis of HeLa cells: Effects on p53 and SUMO

Virology

Volumn 396, Issue 2, 2010, Pages 256-263

  Gomes, Rogério ^a   Guerra Sá, Renata ^b   Arruda, Eurico ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

Apoptosis; Coxsackievirus B5; p53; SUMO; UBC9

Indexed keywords

PROTEASOME; PROTEIN MDM2; PROTEIN P53; PROTEIN UBC9; SUMO PROTEIN;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B5; GENE TRANSLOCATION; HELA CELL; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RECEPTOR INTRINSIC ACTIVITY; SUMOYLATION;

APOPTOSIS; CELL NUCLEUS; COXSACKIEVIRUS INFECTIONS; CYTOCHROMES C; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PROTEASOME ENDOPEPTIDASE COMPLEX; SUMO-1 PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-CONJUGATING ENZYMES;

COXSACKIEVIRUS; ENTEROVIRUS; PICORNAVIRIDAE;

EID: 70749151578     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.005     Document Type: Article

References (34)

1. Ahuja D., Saenz-Robles M.T., and Pipas J.M. SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24 52 (2005) 7729-7745
2. Barco A., Feduchi E., and Carrasco L. Poliovirus protease 3C(pro) kills cells by apoptosis. Virology 266 2 (2000) 352-360
3. Boggio R., and Chiocca S. Gam1 and the SUMO pathway. Cell Cycle 4 4 (2005) 533-535
4. Boggio R., and Chiocca S. Viruses and sumoylation: recent highlights. Curr. Opin. Microbiol. 9 4 (2006) 430-436
5. Buenz E.J., and Howe C.L. Picornaviruses and cell death. Trends Microbiol. 14 1 (2006) 28-36
6. Buschmann T., Fuchs S.Y., Lee C.G., Pan Z.Q., and Ronai Z. SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101 7 (2000) 753-762
7. Chen W., and Hahn W.C. SV40 early region oncoproteins and human cell transformation. Histol. Histopathol. 18 2 (2003) 541-550
8. Chiocca S. Viral control of the SUMO pathway: Gam1, a model system. Biochem. Soc. Trans. 35 Pt. 6 (2007) 1419-1421
9. Colombo R., Boggio R., Seiser C., Draetta G.F., and Chiocca S. The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1. EMBO Rep. 3 11 (2002) 1062-1068
10. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 2 (2004) 205-219
11. Delhaye S., van Pesch V., and Michiels T. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78 8 (2004) 4357-4362
12. Endres A.S., Helms T., Steinfuhrer S., and Meisel H. Transient broca aphasia in an elderly man caused by coxsackievirus B5. J. Neurol. 249 9 (2002) 1318-1319
13. Everett R.D., and Chelbi-Alix M.K. PML and PML nuclear bodies: implications in antiviral defence. Biochimie 89 6-7 (2007) 819-830
14. Gao G., Zhang J., Si X., Wong J., Cheung C., McManus B., and Luo H. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice. Am. J. Physiol. Heart Circ. Physiol. 295 1 (2008) H401-H408
15. Henke A., Launhardt H., Klement K., Stelzner A., Zell R., and Munder T. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J. Virol. 74 9 (2000) 4284-4290
16. Honda R., Tanaka H., and Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420 1 (1997) 25-27
17. Hwang H.Y., Kim J.Y., Lim J.Y., Chung S.K., Nam J.H., and Park S.I. Coxsackievirus B3 modulates cell death by downregulating activating transcription factor 3 in HeLa cells. Virus Res. 130 1-2 (2007) 10-17
18. Lavin M.F., and Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 13 6 (2006) 941-950
19. Lee M.H., Lee S.W., Lee E.J., Choi S.J., Chung S.S., Lee J.I., Cho J.M., Seol J.H., Baek S.H., Kim K.I., Chiba T., Tanaka K., Bang O.S., and Chung C.H. SUMO-specific protease SUSP4 positively regulates p53 by promoting Mdm2 self-ubiquitination. Nat. Cell Biol. 8 12 (2006) 1424-1431
20. Li M.L., Hsu T.A., Chen T.C., Chang S.C., Lee J.C., Chen C.C., Stollar V., and Shih S.R. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology 293 2 (2002) 386-395
21. Luo H., Zhang J., Dastvan F., Yanagawa B., Reidy M.A., Zhang H.M., Yang D., Wilson J.E., and McManus B.M. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. J. Virol. 77 1 (2003) 1-9
22. Martin U., Nestler M., Munder T., Zell R., Sigusch H.H., and Henke A. Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions. Med. Microbiol. Immunol. 193 2-3 (2004) 133-139
23. McLean J.E., Ruck A., Shirazian A., Pooyaei-Mehr F., and Zakeri Z.F. Viral manipulation of cell death. Curr. Pharm. Des. 14 3 (2008) 198-220
24. Moschovi M., Sterpi P., Youroukos S., and Tzortzatou-Stathopoulou F. Encephalitis and myocarditis in a child with acute lymphoblastic leukemia: role of coxsackievirus B5?. Pediatr. Hematol. Oncol. 19 3 (2002) 205-210
25. Nicholls D.G., and Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 23 4 (2000) 166-174
26. Pallansch M.A. Coxsackievirus B epidemiology and public health concerns. Curr. Top. Microbiol. Immunol. 223 (1997) 13-30
27. Pampin, M., Simonin, Y., Blondel, B., Percherancier, Y., Chelbi-Alix, M.K., 2006. Cross Talk between PML and p53 during Poliovirus Infection: Implications for Antiviral Defense, Vol. 80, pp. 8582-8592.
28. Scheffner M., and Whitaker N.J. Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. Semin. Cancer Biol. 13 1 (2003) 59-67
29. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 6 (1990) 1129-1136
30. Si X., McManus B.M., Zhang J., Yuan J., Cheung C., Esfandiarei M., Suarez A., Morgan A., and Luo H. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J. Virol. 79 13 (2005) 8014-8023
31. Si X., Wang Y., Wong J., Zhang J., McManus B.M., and Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J. Virol. 81 7 (2007) 3142-3150
32. Szalay G., Meiners S., Voigt A., Lauber J., Spieth C., Speer N., Sauter M., Kuckelkorn U., Zell A., Klingel K., Stangl K., and Kandolf R. Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes. Am. J. Pathol. 168 5 (2006) 1542-1552
33. Watson I.R., and Irwin M.S. Ubiquitin and ubiquitin-like modifications of the p53 family. Neoplasia 8 8 (2006) 655-666
34. Wong J., Zhang J., Si X., Gao G., and Luo H. Inhibition of the extracellular signal-regulated kinase signaling pathway is correlated with proteasome inhibitor suppression of coxsackievirus replication. Biochem. Biophys. Res. Commun. 358 3 (2007) 903-907